Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin

References

• Acharya S, Sahoo SK. (2011). PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170–83.
   PubMed Web of Science ®Google Scholar
• Alam N, Khare V, Dubey R, et al. (2014). Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile. Mater Sci Eng C 38:85–93.
   PubMed Web of Science ®Google Scholar
• Avgoustakis K, Beletsi A, Panagi Z, et al. (2002). PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release 79:123–35.
   PubMed Web of Science ®Google Scholar
• Barbieri S, Sonvico F, Como C, et al. (2013). Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake. J Control Release 167:276–83.
   PubMed Web of Science ®Google Scholar
• Cervera MF, Heinämäki J, de la Paz N, et al. (2011). Effects of spray drying on physicochemical properties of chitosan acid salts. AAPS PharmSciTech 12:637–49.
   PubMed Web of Science ®Google Scholar
• Chan JM, Zhang L, Yuet KP, et al. (2009). PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 30:1627–34.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Shi H, Huang H, et al. (2015). Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles. Chem Commun 51:17536–9.
   PubMed Web of Science ®Google Scholar
• Cheow WS, Hadinoto K. (2011). Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles. Colloids Surf B Biointerfaces 85:214–20.
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, et al. (2008). Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14:1310–16.
   PubMed Web of Science ®Google Scholar
• Comis RL. Cisplatin: the future. Semin Oncol 1994;21:109–13.
   PubMed Web of Science ®Google Scholar
• Dixit N, Vaibhav K, Pandey RS, et al. (2015). Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles. Biomed Pharmacother 69:1–10.
   PubMed Web of Science ®Google Scholar
• Drebushchak VA, Shakhtshneider TP, Apenina SA, et al. (2006). Thermoanalytical investigation of drug–excipient interaction. J Therm Anal Calorim 86:303–9.
   Web of Science ®Google Scholar
• Elsabahy M, Wooley KL. (2012). Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 41:2545–61.
   PubMed Web of Science ®Google Scholar
• Fang RH, Aryal S, Hu C-M, Zhang L. (2010). Quick synthesis of lipid–polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir 26:16958–62.
   PubMed Web of Science ®Google Scholar
• Feng S-S, Zhao L, Tang J. (2011). Nanomedicine for oral chemotherapy. Nanomedicine (Lond) 6:407–10.
   PubMed Web of Science ®Google Scholar
• Fricker G, Kromp T, Wendel A, et al. (2010). Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res 27:1469–86.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang L, Lv P, Zhang P. (2015). Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer. Oncol Lett 9:1065–72.
   PubMed Web of Science ®Google Scholar
• Hamelers IH, De Kroon AI. (2007). Nanocapsules: a novel lipid formulation platform for platinum-based anti-cancer drugs. J Liposome Res 17:183–9.
   PubMed Web of Science ®Google Scholar
• Huo D, Deng S, Li L, Ji J. (2005). Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm 289:63–7.
   PubMed Web of Science ®Google Scholar
• Javaid MA, Khera RA, Zia KM, et al. (2018). Synthesis and characterization of chitosan modified polyurethane bio-nanocomposites with biomedical potential. Int J Biol Macromol 115:375.
   PubMed Web of Science ®Google Scholar
• Jeong YI, Kim ST, Jin SG, et al. (2008). Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation . J Pharm Sci 97:1268–76.
   PubMed Web of Science ®Google Scholar
• Kai MP, Keeler AW, Perry JL, et al. (2015). Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle. J Control Release 204:70–7.
   PubMed Web of Science ®Google Scholar
• Kelmann RG, Kuminek G, Teixeira HF, Koester LS. (2007). Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process. Int J Pharm 342:231–9.
   PubMed Web of Science ®Google Scholar
• Kim J-H, Kim Y-S, Park K, et al. (2008). Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 127:41–9.
   PubMed Web of Science ®Google Scholar
• Kumar MNR. (2000). A review of chitin and chitosan applications. React Funct Polym 46:1–27.
   Web of Science ®Google Scholar
• Li X, Li R, Qian X, et al. (2008a). Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur J Pharm Biopharm 70:726–34.
   PubMed Web of Science ®Google Scholar
• Li Y, Wong HL, Shuhendler AJ, et al. (2008b). Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles. J Control Release 128:60–70.
   PubMed Web of Science ®Google Scholar
• Mandal B, Bhattacharjee H, Mittal N, et al. (2013). Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine 9:474–91.
   PubMed Web of Science ®Google Scholar
• Mandal B, Mittal NK, Balabathula P, et al. (2016). Development and in vitro evaluation of core–shell type lipid–polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer. Eur J Pharm Sci 81:162–71.
   PubMed Web of Science ®Google Scholar
• Mei L, Zhang Z, Zhao L, et al. (2013). Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev 65:880–90.
   PubMed Web of Science ®Google Scholar
• Nair KM, Sivakumar B, Rao BN. (1981). The rabbit as an animal model to study pharmacokinetics of levonorgestrel in women. Contraception 23:89–98.
   PubMed Web of Science ®Google Scholar
• Nakano K, Ike O, Wada H, et al. (1997). Oral sustained-release cisplatin preparation for rats and mice . J Pharm Pharmacol 49:485–90.
   PubMed Web of Science ®Google Scholar
• Navolotskii DV, Ivanenko NB, Solovyev ND, et al. (2015). Pharmacokinetics and tissue distribution of novel platinum containing anticancer agent BP‐C1 studied in rabbits using sector field inductively coupled plasma mass spectrometry. Drug Test Anal 7:737–44.
   PubMed Web of Science ®Google Scholar
• Prabaharan M. (2015). Chitosan-based nanoparticles for tumor-targeted drug delivery. Int J Biol Macromol 72:1313–22.
   PubMed Web of Science ®Google Scholar
• Prodana M, Voiculet A, Garea S, et al. (2014). Synthesis, characterization and controlled toxicity of a novel hybrid material based on cisplatin and docetaxel. Central Eur J Chem 12:1008–15.
   Google Scholar
• Reardon PJ, Parhizkar M, Harker AH, et al. (2017). Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment. Int J Nanomed 12:3913.
   PubMed Web of Science ®Google Scholar
• Robinson J. (1996). Introduction: semi-solid formulations of oral drug delivery. Bull Tech Gattefosse 89:11–4.
   Google Scholar
• Sonawane SJ, Kalhapure RS, Rambharose S, et al. (2016). Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: in vitro and in silico studies. Int J Pharm 504:1–10.
   PubMed Web of Science ®Google Scholar
• Sonvico F, Cagnani A, Rossi A, et al. (2006). Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. Int J Pharm 324:67–73.
   PubMed Web of Science ®Google Scholar
• Souza MP, Vaz AF, Correia MT, et al. (2014). Quercetin-loaded lecithin/chitosan nanoparticles for functional food applications. Food Bioprocess Technol 7:1149–59.
   Web of Science ®Google Scholar
• Spenlehauer G, Veillard M, Benoit JP. (1986). Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. J Pharm Sci 75:750–5.
   PubMed Web of Science ®Google Scholar
• Tahir N, Madni A, Balasubramanian V, et al. (2017). Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications. Int J Pharm 533:156–68.
   PubMed Web of Science ®Google Scholar
• Tran TH, Nguyen TD, Poudel BK, et al. (2015). Development and evaluation of artesunate-loaded chitosan-coated lipid nanocapsule as a potential drug delivery system against breast cancer. AAPS PharmSciTech 16:1307–16.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou J, Qiu L, et al. (2014). Cisplatin–alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells. Biomaterials 35:4297–309.
   PubMed Web of Science ®Google Scholar
• Xu P, Van Kirk EA, Li S, et al. (2006). Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloids Surf B Biointerfaces 48:50–7.
   PubMed Web of Science ®Google Scholar
• Yue Z-G, Wei W, Lv P-P, et al. (2011). Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 12:2440–6.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang L. (2010). Lipid–polymer hybrid nanoparticles: synthesis, characterization and applications. Nano Life 1:163–73.
   Google Scholar
• Zhang T, Ma J, Li C, et al. (2017). Core-shell lipid polymer nanoparticles for combined chemo and gene therapy of childhood head and neck cancers. Oncol Rep 37:1653–61.
   PubMed Web of Science ®Google Scholar